These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3003910)

  • 1. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients.
    Shero JH; Bordwell B; Rothfield NF; Earnshaw WC
    Science; 1986 Feb; 231(4739):737-40. PubMed ID: 3003910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I.
    Guldner HH; Szostecki C; Vosberg HP; Lakomek HJ; Penner E; Bautz FA
    Chromosoma; 1986; 94(2):132-8. PubMed ID: 2428564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to topoisomerase I in sera from patients with scleroderma.
    Shero JH; Bordwell B; Rothfield NF; Earnshaw WC
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():138-40. PubMed ID: 3039129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-topoisomerase I autoantibodies in systemic sclerosis.
    Czömpöly T; Simon D; Czirják L; Németh P
    Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant DNA topoisomerase I is recognized and inhibited by human Scl-70 sera autoantibodies.
    Agris PF; Parks R; Bowman L; Guenther RH; Kovacs SA; Pelsue S
    Exp Cell Res; 1990 Aug; 189(2):276-9. PubMed ID: 2164485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of anti-Scl-70 antibodies in scleroderma: increased sensitivity of detection using purified DNA topoisomerase I from calf thymus.
    Tsay GJ; Fann RH; Hwang J
    J Rheumatol; 1990 Oct; 17(10):1314-9. PubMed ID: 2174971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].
    Johanet C; Agostini MM; Vayssairat M; Abuaf N
    Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of molecular cloning methods to map the distribution of epitopes on topoisomerase I (Scl-70) recognized by sera of scleroderma patients.
    D'Arpa P; White-Cooper H; Cleveland DW; Rothfield NF; Earnshaw WC
    Arthritis Rheum; 1990 Oct; 33(10):1501-11. PubMed ID: 1699543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibodies against topoisomerase I (Scl-70)--comparative studies on detection with recombinant protein antigens and natural enzyme].
    Seelig HP; Schröter H; Ehrfeld H; Renz M
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):505-11. PubMed ID: 7856253
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
    Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
    J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral manifestations of Systemic Sclerosis and Correlation with anti-Topoisomerase I Antibodies (SCL-70).
    Bajraktari IH; Kryeziu A; Sherifi F; Bajraktari H; Lahu A; Bajraktari G
    Med Arch; 2015 Jun; 69(3):153-6. PubMed ID: 26261381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antigenic region of topoisomerase I in DNA polymerase chain reaction-generated fragments recognized by autoantibodies of scleroderma patients.
    Piccinini G; Cardellini E; Reimer G; Arnett FC; Durban E
    Mol Immunol; 1991; 28(4-5):333-9. PubMed ID: 1712070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the antigen reactive with anti-Scl-70 antibodies and its application in an enzyme-linked immunosorbent assay.
    Juarez C; Vila JL; Gelpi C; Agusti M; Amengual MJ; Martinez MA; Rodriguez JL
    Arthritis Rheum; 1988 Jan; 31(1):108-15. PubMed ID: 2830889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase.
    Maul GG; French BT; van Venrooij WJ; Jimenez SA
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5145-9. PubMed ID: 3014535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
    Henry PA; Atamas SP; Yurovsky VV; Luzina I; Wigley FM; White B
    Arthritis Rheum; 2000 Dec; 43(12):2733-42. PubMed ID: 11145031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redefining the Scl-70 indirect immunofluorescence pattern: autoantibodies to DNA topoisomerase I yield a specific compound immunofluorescence pattern.
    Dellavance A; Gallindo C; Soares MG; da Silva NP; Mortara RA; Andrade LE
    Rheumatology (Oxford); 2009 Jun; 48(6):632-7. PubMed ID: 19395540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality?
    Mahler M; Silverman ED; Schulte-Pelkum J; Fritzler MJ
    Autoimmun Rev; 2010 Sep; 9(11):756-60. PubMed ID: 20601198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay.
    Hildebrandt S; Weiner ES; Senecal JL; Noell GS; Earnshaw WC; Rothfield NF
    Clin Immunol Immunopathol; 1990 Dec; 57(3):399-410. PubMed ID: 2173985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma).
    Shoenfeld Y; Grunebaum E; Laufer M; Zurgil N; Bakimer R; Lunderschmidt A; Valentini G; Tirri G; Blank M
    Isr J Med Sci; 1996 Jul; 32(7):537-42. PubMed ID: 8756980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of protein components reactive with anti-PM/Scl autoantibodies.
    Gelpi C; Algueró A; Angeles Martinez M; Vidal S; Juarez C; Rodriguez-Sanchez JL
    Clin Exp Immunol; 1990 Jul; 81(1):59-64. PubMed ID: 2199097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.